FTC US Federal Trade Commission Begins Making the Case for Unwinding Illumina's Grail Purchase Premium The FTC claimed that Illumina can and will disadvantage Grail's rivals, but lawyers for the companies said the merger's benefits outweigh "speculative harms." Illumina's 'Maverick' Move Secures Grail Deal But Risks Loom Premium Illumina faces potential fines in Europe for moving ahead with the deal but felt it had to act now in order to make sure it went through at all. Illumina Moves Ahead with Grail Acquisition As GenomeWeb reports Illumina has moved ahead with its acquisition of Grail as US and EU regulators scrutinize the deal. Illumina Parries FTC Challenge to Grail Acquisition With Deals for Competing Customers Premium The US Federal Trade Commission's recent challenge raises the question who Illumina can acquire while remaining a quasi-monopolist for sequencing equipment. FTC Moves to Block Illumina's $8B Grail Acquisition Illumina said it plans to "vigorously defend" the deal and oppose the FTC, which previously helped scuttle Illumina's proposed acquisition of Pacific Biosciences. Jan 2, 2020 Illumina, Pacific Biosciences Abandon $1.2B Acquisition Deal Oct 23, 2019 National Council on Disability Recommends More Regulation of NIPT Jan 31, 2014 FTC Says Sale of Certain Thermo Fisher Assets to GE Healthcare is Required for Life Tech Deal OK Jan 8, 2014 FTC, GeneLink and Subsidiary Reach Deal to Settle Charges of False Advertising Jun 6, 2013 Thermo Fisher Plans Public Offering of $2.2B to Fund Life Tech Buy; Expects Another FTC Request Jan 8, 2013 Illumina Withdraws Complete Genomics Bid Jan 7, 2013 BGI Bid to Acquire Complete Genomics Passes US Antitrust Hurdle; Tender Offer Extended Again Nov 6, 2012 FTC Wants More Information About BGI-Shenzhen Buy of Complete Genomics Dec 8, 2011 LabCorp's Bid for Orchid Cellmark Finally Cleared by FTC Nov 7, 2011 LabCorp Extends Proposed Orchid Cellmark Buy Again Oct 20, 2011 PerkinElmer Acquisition of Caliper Clears Anti-Trust Review Sep 12, 2011 LabCorp Extends Offer for Orchid for Sixth Time Jun 16, 2011 LabCorp Further Extends Offer for Orchid Cellmark May 18, 2011 LabCorp Extends Tender Offer for Orchid Cellmark as FTC Requests More Information Mar 9, 2011 FTC Clears Danaher's Proposed Acquisition of Beckman Coulter Nov 18, 2010 LabCorp Buy of Genzyme Genetics Clears FTC Feb 10, 2010 Myriad Defends Policy of Urging Docs to Genetically Counsel BRACAnalysis Customers Premium Jan 22, 2010 European Commission OKs Agilent's Acquisition of Varian; FTC Approval Still Pending Premium Nov 3, 2009 FTC Asks MDS, Danaher for More Information on Acquisition Sep 30, 2009 What's In a Name? Experts Question Bill Calling DTC Genomics 'Post-CLIA Bioinformatics Services' Premium Load More Breaking News DNAe, Imperial College London, U of Leicester to Develop NGS-Based Breast Cancer Monitoring Test Illumina, Israel Ministry of Health to Pilot Genome Sequencing for Diagnosing Critically Ill Infants GenomSys Gains CE Mark for New Genomic Analysis Software Thermo Fisher Scientific Q3 Revenues up 9 Percent BTIG Initiates Coverage of LumiraDx With Buy Rating Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms The Scan Panel Recommends Pfizer-BioNTech Vaccine for Kids CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old. Sharing How to Make It Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times. Bring it Back In Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray. Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.